What is the primary purpose of BioOrbit’s Box-E unit sent to the International Space Station?

The primary purpose of BioOrbit’s Box-E unit is to grow ultra-pure protein crystals in microgravity for use in developing self-injectable cancer drugs—enabling concentrated, low-viscosity formulations that can be administered at home via injection pen instead of requiring hospital-based intravenous infusions.

How does microgravity improve drug crystallisation compared to Earth-based methods, according to Dr Katie King?

According to Dr Katie King, microgravity enables a 'much better, more superior crystallisation process' than on Earth because gravity negatively impacts crystallisation—especially for large, flexible protein and antibody drugs—allowing space-grown crystals to achieve higher purity, stability, and structural quality essential for effective, injectable formulations.

Final Frontier for Meds? UK Startup Sends Drug-Making Into Space

May 23, 2026

UK startup BioOrbit launched a unit to the International Space Station to produce ultra-pure protein crystals for self-injected cancer drugs via microgravity. Backed by £9.8m funding and partnerships like Merck, the technology aims to transform drug delivery and reduce hospital dependency.

theguardian

2026-05-23

Final Frontier for Meds? UK Startup Sends Drug-Making Into Space

Final Frontier for Meds? UK Startup Sends Drug-Making Into Space

FAQ